The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mckay Susan D Bateson since 2006.
The trader's CIK number is 1191234.
At the time of the last reporting, Mckay Susan D Bateson was the Senior Vice Presiden of Human Genome Sciences Inc. (stock ticker symbol HGSI).
Also see all insider trading activities at Human Genome Sciences Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2011 | HGSI | 0 | $0 | 27,000 | $780,000 | 24,000 | $12,480 |
2010 | HGSI | 0 | $0 | 125,200 | $3,539,858 | 134,453 | $1,639,308 |
2009 | HGSI | 0 | $0 | 292,154 | $7,133,861 | 283,790 | $2,464,004 |
2007 | HGSI | 0 | $0 | 2,400 | $29,460 | 8,000 | $54,720 |
2006 | HGSI | 0 | $0 | 4,800 | $59,616 | 40,852 | $279,427 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-04-28 | HGSI | Sale | 3,000 | 30.00 | 90,000 |
2011-04-20 | HGSI | Option Ex | 24,000 | .52 | 12,480 |
2011-04-20 | HGSI | Sale | 24,000 | 28.75 | 690,000 |
2010-04-21 | HGSI | Option Ex | 9,253 | 10.76 | 99,516 |
2010-03-01 | HGSI | Option Ex | 85,200 | 12.56 | 1,070,112 |
2010-03-01 | HGSI | Sale | 85,200 | 28.08 | 2,392,501 |
2010-02-01 | HGSI | Sale | 20,000 | 26.49 | 529,880 |
2010-02-01 | HGSI | Option Ex | 20,000 | 12.56 | 251,200 |
2010-01-04 | HGSI | Sale | 15,832 | 30.88 | 488,907 |
2010-01-04 | HGSI | Option Ex | 20,000 | 10.92 | 218,480 |
2010-01-04 | HGSI | Sale | 4,168 | 30.85 | 128,570 |
2009-12-22 | HGSI | Sale | 10,000 | 30.00 | 300,000 |
2009-12-21 | HGSI | Option Ex | 20,000 | 1.25 | 25,059 |
2009-12-21 | HGSI | Sale | 20,000 | 28.68 | 573,700 |
2009-12-16 | HGSI | Option Ex | 35,634 | 8.44 | 300,644 |
2009-11-03 | HGSI | Sale | 10,000 | 27.00 | 270,000 |
2009-11-02 | HGSI | Sale | 193,261 | 24.96 | 4,823,408 |
2009-11-02 | HGSI | Option Ex | 189,263 | 10.29 | 1,946,948 |
2009-10-19 | HGSI | Option Ex | 38,893 | 4.92 | 191,353 |
2009-10-19 | HGSI | Sale | 38,893 | 21.00 | 816,753 |
2009-08-26 | HGSI | Sale | 10,000 | 22.00 | 220,000 |
2009-07-21 | HGSI | Sale | 10,000 | 13.00 | 130,000 |
2007-11-29 | HGSI | Option Ex | 8,000 | 6.84 | 54,720 |
2007-02-02 | HGSI | Sale | 1,200 | 12.00 | 14,400 |
2007-01-03 | HGSI | Sale | 1,200 | 12.55 | 15,060 |
2006-12-01 | HGSI | Sale | 1,200 | 12.30 | 14,760 |
2006-11-15 | HGSI | Option Ex | 15,852 | 6.84 | 108,427 |
2006-11-01 | HGSI | Sale | 1,200 | 13.38 | 16,056 |
2006-10-02 | HGSI | Sale | 1,200 | 12.00 | 14,400 |
2006-09-18 | HGSI | Sale | 1,200 | 12.00 | 14,400 |
2006-01-11 | HGSI | Option Ex | 25,000 | 6.84 | 171,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mckay Susan D Bateson (Senior Vice Presiden of Human Genome Sciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.